...
首页> 外文期刊>Biochemical Society Transactions >p110 is required for innate immunity to transplantable lymphomas
【24h】

p110 is required for innate immunity to transplantable lymphomas

机译:p110是先天免疫对移植淋巴瘤所必需的

获取原文
获取原文并翻译 | 示例
           

摘要

NK cell (natural killer cells) are lymphocytes of innate immunity that kill tumour cells and respond to infections, without prior stimulation. A balance of activating and inhibitory signals regulates NK cell cytotoxicity, but the molecular mechanisms are not fully understood. General inhibitors of PI3K (phosphoinositide 3-kinase) suppress cytotoxicity in human and mouse NK cells. However, which isoforms and how they regulate NK cell activation is unknown, and no data have been published on mice carrying PI3K mutations. p110 expression is restricted to leucocytes, where it plays central roles in lymphocyte development and signalling. We have used mice carrying a catalytically inactive mutant form of p110 in order to determine its role in NK cell biology. We show here that p110 is not required to kill tumour cells, but unexpectedly p110 mutant mice failed to fully reject transplanted lymphomas. Our results show for the first time a critical role for p110 in NK cell biology in vivo. ?2007 Biochemical Society
机译:NK细胞(天然杀伤细胞)是杀死肿瘤细胞并对感染反应的先天免疫的淋巴细胞,而没有事先刺激。激活和抑制信号的平衡调节NK细胞细胞毒性,但分子机制尚未完全了解。 PI3K(磷酸肌醇3-激酶)的一般抑制剂抑制人和小鼠NK细胞中的细胞毒性。然而,哪些同工型及其如何调节NK细胞激活是未知的,并且尚未发布有关携带PI3K突变的小鼠的数据。 p110表达仅限于白细胞,在淋巴细胞发育和信号传导中起着核心作用。我们已经使用了携带p110催化无效突变体形式的小鼠,以确定其在NK细胞生物学中的作用。我们在这里表明,杀死肿瘤细胞不需要P110,但意外的P110突变小鼠未能完全拒绝移植的淋巴瘤。我们的结果首次表明P110在体内NK细胞生物学中的关键作用。 2007年生化社会

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号